Craniopharyngioma and Metabolic Syndrome: A 5-Year Follow-Up Single-Center Experience
暂无分享,去创建一个
L. Cavallo | D. Solari | A. Colao | T. Somma | C. Di Somma | E. Scarano | E. Riccio | F. Romano | R. Arianna
[1] New Perspectives in Health , 2022 .
[2] Xiaoming Zhu,et al. Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases , 2021, Frontiers in Endocrinology.
[3] F. Esposito,et al. Biological Rhythm and Chronotype: New Perspectives in Health , 2021, Biomolecules.
[4] T. Battelino,et al. Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma , 2020, Hormone Research in Paediatrics.
[5] M. Jensterle,et al. Advances in the Management of Craniopharyngioma in Children and Adults , 2019, Radiology and oncology.
[6] B. Lu,et al. Endocrine and Metabolic Outcomes After Transcranial and Endoscopic Endonasal Approaches for Primary Resection of Craniopharyngiomas. , 2019, World neurosurgery.
[7] M. Pinheiro,et al. Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center , 2018, Hormone and Metabolic Research.
[8] M. Murad,et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[9] L. Beilin,et al. Dual Energy X-Ray Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the ‘Gold Standard’ Tarnished? , 2016, PloS one.
[10] P. Steinbok. Craniopharyngioma in Children: Long-term Outcomes , 2015, Neurologia medico-chirurgica.
[11] P. Beck‐Peccoz,et al. Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma , 2015, Journal of Endocrinological Investigation.
[12] R. Pieters,et al. Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer , 2012, PloS one.
[13] R. Lustig. Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment , 2011, Front. Endocrin..
[14] L. Iughetti,et al. Obesity and craniopharyngioma , 2011, Italian journal of pediatrics.
[15] S. A. Jayakody,et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans , 2011, Proceedings of the National Academy of Sciences.
[16] Taninee Sahakitrungruang,et al. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery , 2011, European Journal of Pediatrics.
[17] M. Riva,et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. , 2011, Journal of neurosurgery.
[18] F. Saggioro,et al. CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas , 2010, Hormones & cancer.
[19] B. Zemel,et al. Energy expenditure in obesity associated with craniopharyngioma , 2010, Child's Nervous System.
[20] J. Björk,et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. , 2009, European Journal of Endocrinology.
[21] B. Scheithauer,et al. The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.
[22] Udo Hoffmann,et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.
[23] S. Puget,et al. Craniopharyngioma , 2007, Orphanet journal of rare diseases.
[24] I. Lemieux,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[25] R. Eckel,et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.
[26] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[27] A. Emser,et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. , 2004, The Journal of clinical endocrinology and metabolism.
[28] I. Lemieux. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[29] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.
[30] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[31] Douglas C. Miller,et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. , 1994, Neurosurgery.
[32] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[33] J. Crigler,et al. Management of craniopharyngioma in childhood. , 1969, Journal of neurosurgery.
[34] Gol'dberg Gm,et al. Squamous cell nests of the pituitary gland as related to the origin of craniopharyngiomas. A study of their presence in the newborn and infants up to age four. , 1960, Archives of pathology.
[35] G. Johannsson,et al. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. , 2018, European journal of endocrinology.
[36] F. Greenway,et al. An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .
[37] S. Cudlip,et al. Craniopharyngiomas. , 2006, Endocrine reviews.
[38] J. Pinkney,et al. Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. , 2005, The American journal of medicine.
[39] C. Cowell,et al. Features of the metabolic syndrome after childhood craniopharyngioma. , 2004, The Journal of clinical endocrinology and metabolism.
[40] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[41] P. Renshaw,et al. [Detection, evaluation, and treatment of high blood cholesterol in adults]. , 2001, Revista panamericana de salud publica = Pan American journal of public health.
[42] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[43] I. Hunter. Squamous metaplasia of cells of the anterior pituitary gland. , 1955, The Journal of pathology and bacteriology.